Usana Health Sciences, Inc. (USNA)
NYSE · Consumer Defensive
Usana Health Sciences, Inc. Operating Income 2016–2026
Usana Health Sciences, Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Usana Health Sciences, Inc. operating income for the quarter ending April 4, 2026 was 13.9 M, a 48.32% decrease year-over-year.
- Usana Health Sciences, Inc. operating income for the twelve months ending April 4, 2026 was 47.5 M, a 37.29% decrease year-over-year.
- Usana Health Sciences, Inc. annual operating income for 2026 was 37.4 M, a 43.56% decrease from 2024.
- Usana Health Sciences, Inc. annual operating income for 2024 was 66.3 M, a 28.74% decrease from 2023.
- Usana Health Sciences, Inc. annual operating income for 2023 was 93.1 M, a 13.51% decrease from 2022.
- Usana Health Sciences, Inc. annual operating income for 2022 was 107.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Usana Health Sciences, Inc. Operating Income — FAQ
Usana Health Sciences, Inc. (USNA) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Usana Health Sciences, Inc.'s operating income?
Usana Health Sciences, Inc. (USNA) reported operating income of $37M for fiscal 2026.
Where can I see USNA's operating income history?
The chart and table above show Usana Health Sciences, Inc.'s operating income by year and by quarter, including the growth rate.